MJayawardena
TL3 Regular · Kuopio, FI
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 11 August 2024 · last posted 18h
144Posts here
2Topics
1Solutions
2.7kLikes received
2.7kLikes given
27Badges
398Days visited
10kPosts read
Stated areas
Recent activity
Full stream-
Coming back to: A structured critique template this community uses Replied, post #70 · Evidence › Study critique · 27 Jul 2026 · 13 likes I read post #68 twice before replying, because I had assumed the opposite. Criticise the method, not the author: a paper with a weak design is not a bad paper by…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #72 · Access › Insurance & coverage · 26 Jul 2026 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
About the Independent verification category Replied, post #5 · Sourcing › Independent verification · 24 Jul 2026 · 6 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #116 · Analytics › Home & field testing · 23 Jul 2026 · 7 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #86 · Compounds › Retatrutide · 23 Jul 2026 · 0 likes Coming back to post #84, because the follow-up matters more than the original answer. Triple agonism: is the effect additive, synergistic, or neither? A phase 2…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #62 · Clinical › Prescriber conversations · 21 Jul 2026 · 9 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
Athletes in weight-category sports: a different risk calculus Replied, post #33 · Clinical › Special populations · 20 Jul 2026 · 7 likes Picking up post #30: that is the part I would want checked first. Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease.…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #15 · Clinical › Prescriber conversations · 19 Jul 2026 · 10 likes This follows post #12 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #13 · Nutrition & Training › Protein & intake · 18 Jul 2026 · 0 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #3 · Compounds › Oral incretins · 16 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #126 · Practice › Reconstitution · 15 Jul 2026 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
What steady state means for the decision to escalate Replied, post #25 · Practice › Dosing & titration · 7 Jul 2026 · 0 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…